About Us

Kiran Turaga, MD, MPH, is Division Chief of Surgical Oncology in the Department of Surgery and Assistant Medical Director for the Clinical Trials Office at Yale Cancer Center. Dr. Turaga joined Yale Cancer Center and Smilow Cancer Hospital from the University of Chicago where he was Vice Chief of the Section of General Surgery and Surgical Oncology, Director of the Surgical Gastrointestinal Cancer Program, and Director of Regional Therapeutics. Widely considered a thought leader in the management of oligometastatic cancer, Dr. Turaga is an expert in regional perfusion including hyperthermic intraperitoneal chemotherapy (HIPEC), a technique that delivers high doses of heated chemotherapy directly to abdominal organs to kill cancer cells that may remain after surgical removal of visible tumors. His research focuses on development of novel diagnostics and therapeutics for oligometastatic cancer and is currently the principal investigator on several clinical trials exploring the interface of immunotherapy and liquid biopsy in the surgical management of cancer. He is also interested in studying how big data systems can be used to provide the most optimal, cost-effective patient care.

Dr. Greenup is an Associate Professor of Surgery (Oncology) and Chief of Breast Surgical Oncology. She provides coordinated, state-of-the-art care to patients with benign and malignant diseases of the breast as part of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center. Learn more about Dr. Greenup She earned her undergraduate degrees in Zoology and Psychology at the University of Wisconsin, where she also completed a Master of Public Health. She received her medical degree from the Medical College of Wisconsin where she also completed her General Surgery residency, and went on to complete a fellowship as part of The Massachusetts General Hospital, Dana-Farber Cancer Institute and Brigham and Women's Hospital Breast Surgery Fellowship. Prior to joining Yale, Dr. Greenup was an Associate Professor of Surgery and Population Health Sciences at the Duke University School of Medicine and Duke Cancer Institute. There she founded the Duke Breast Cancer Outcomes Research Group, and Core Faculty for the Duke Margolis Center for Health Policy. In 2016, she received the National Institutes of Health Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Award to evaluate how financial costs and burden relate to preference-sensitive decisions for breast cancer surgery. In 2017, she was named the American College of Surgeons and the American Society of Breast Surgeons Health Policy Scholar. Her research focuses on aligning patient-centered care with high-quality, lower cost treatment. She serves on several national committees, including the Alliance in Clinical Oncology Ethics and Value Committees, the American College of Surgeons Cancer Care Delivery Task Force, the American Society of Breast Surgeons Legislative Committee, and the Editorial Board for the Annals of Surgical Oncology.

Dr. Jennifer Ogilvie is Associate Professor of Surgery and Chief, Section of Endocrine Surgery at Yale School of Medicine. She completed training in General Surgery and fellowship training in Endocrine Surgery at the University of California, San Francisco. Prior to Yale, she held faculty positions at the University of Pittsburgh Medical Center and New York University Langone Health, where she was also Director of Endocrine Surgery at Bellevue Hospital. Her clinical interests focus on the optimal surgical treatment of thyroid, parathyroid and adrenal tumors. Her research interests are in surgical education and the function of surgical teams, shared clinical decision making, and clinical outcomes in Endocrine Surgery.

Sajid Khan, MD is an Associate Professor of Surgery (Oncology), Chief of Hepato-Pancreato-Biliary & Mixed Tumors, and Co-Director of Team Science at Yale School of Medicine. Dr. Khan is nationally recognized for superb clinical care and excellence in cancer research. He earned his medical degree from SUNY Upstate Medical University in Syracuse, NY and is Board Certified in both Complex General Surgical Oncology and General Surgery. He completed general surgery training at Oregon Health & Science University in Portland, OR and Albert Einstein College of Medicine/Montefiore in Bronx, NY. He also completed a research fellowship in surgical oncology at Memorial Sloan-Kettering Cancer Center in New York, NY and a clinical and research fellowship in surgical oncology at University of Chicago Medical Center in Chicago, IL. Watch a video with Dr. Sajid Khan >>. Dr. Khan is dedicated to improving the lives of cancer patients by his busy surgical practice, federally funded research, leadership by example, and kindness. Dr. Khan's surgical oncology practice specializes in patients with tumors of the liver, pancreas, bile ducts, stomach, and colon. Additionally he treats individuals diagnosed with melanoma, neuroendocrine tumors, and pancreatic cysts. He has performed over 1,600 surgeries throughout the Yale Health System. His commitment to his patients and their families incorporates a multidisciplinary team approach, excellent communication, and minimally invasive surgery to provide an exceptional patient experience. Nationally, he has been named Top Doctors by Castle Connolly and consistently is in top percentile ranks for patient satisfaction. At the Yale Cancer Center, he is Co-Director of the Hepatic Arterial Infusion Pump Program, and Co-Leader of the Advanced Hepatobiliary Disease Program. Dr. Khan is a federally funded, well published, surgeon-scientist who uses modern molecular biology (focused on metabolomics and transcriptomics) to improve society's understanding and treatment of patients with gastrointestinal cancers. His gastrointestinal surgical oncology focused research has been consistently funded by the National Institutes of Health/National Cancer Institute (R01s, R21s) and incorporates principles of team science. The Khan Lab performs translational scientific research to study the scientific underpinnings of liver metastasis and identifies cancer patients who may benefit from liver surgery. In addition, the Khan Lab studies the relationship of tumor metabolites and RNA expression with race/ethnicity and sex. He also performs clinical outcomes research for all types of gastrointestinal cancers. His lab’s research is regularly presented at national and international scientific meetings, has >100 publications in prestigious scientific journals, and is featured in national media outlets. Dr. Khan is Chair of the Society of Surgery of the Alimentary Tract (SSAT) Research Committee, on the Editorial Board for the Annals of Surgical Oncology, and Institutional Representative for the Society of University Surgeons (SUS). He is an active member of the Society of Surgery of the Alimentary Tract (SSAT), Society of Surgical Oncology (SSO), Society of University Surgeons (SUS), Surgical Biology Club (SBC), National Comprehensive Cancer Center (NCCN), American College of Surgeons (ACS), Association for Academic Surgery (AAS), Southwest Oncology Group (SWOG), American Society of Clinical Oncology (ASCO), Yale Center for Clinical Investigation (YCCI), and Yale Cancer Center.